Drug Profile
Research programme: human intrinsic factor/vitamin B12 - Xeragenx
Alternative Names: B12-rhIF; Cobalok™; rhIF-B12Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Xeragenx Plant Sciences
- Class Proteins; Vitamin B12 analogues
- Mechanism of Action Vitamin B12 receptor protein agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Vitamin B deficiency
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Vitamin-B-deficiency in USA (PO, Granules)
- 08 Jul 2016 Early research in Vitamin B deficiency in USA (PO)